Mirae Asset Global Investments
VNDA icon

Mirae Asset Global Investments’s Vanda Pharmaceuticals VNDA Stock Holding History

Mirae Asset Global Investments’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.5K Sell
2,689
-394
-13% -$2.57K ﹤0.01% 1511
2026
Q1 		$21.3K Buy
3,083
+211
+7% +$1.63K ﹤0.01% 1424
2025
Q4 		$25.3K Buy
2,872
+588
+26% +$3.24K ﹤0.01% 1507
2025
Q3 		$11.4K Buy
2,284
+7
+0.3% +$32 ﹤0.01% 1561
2025
Q2 		$10.7K Buy
2,277
+326
+17% +$1.43K ﹤0.01% 1481
2025
Q1 		$9.15K Buy
1,951
+8
+0.4% +$37 ﹤0.01% 1477
2024
Q4 		$9.35K Sell
1,943
-165
-8% -$792 ﹤0.01% 1520
2024
Q3 		$9.84K Buy
2,108
+370
+21% +$1.98K ﹤0.01% 1498
2024
Q2 		$10.1K Sell
1,738
-26,130
-94% -$135K ﹤0.01% 1463
2024
Q1 		$185K Buy
27,868
+272
+1% +$1.09K ﹤0.01% 2281
2023
Q4 		$116K Buy
27,596
+85
+0.3% +$343 ﹤0.01% 2435
2023
Q3 		$119K Sell
27,511
-7,474
-21% -$41.5K ﹤0.01% 2424
2023
Q2 		$231K Sell
34,985
-1,291
-4% -$8.28K ﹤0.01% 2286
2023
Q1 		$246K Buy
36,276
+8,684
+31% +$61.1K ﹤0.01% 2255
2022
Q4 		$204K Buy
27,592
+3,374
+14% +$32.9K ﹤0.01% 2289
2022
Q3 		$239K Buy
24,218
+7,111
+42% +$75.1K ﹤0.01% 2265
2022
Q2 		$187K Buy
+17,107
New +$177K ﹤0.01% 2167

Other funds holding VNDA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Janney Montgomery Scott
Janney Montgomery Scott Philadelphia, Pennsylvania $51.6B AUM 27.34% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Mirae Asset Global Investments's VNDA Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its Vanda Pharmaceuticals (VNDA) stake by 13% in Q2 2026, selling an estimated $2.57K and leaving 2,689 shares worth $16.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1511.

Mirae Asset Global Investments first reported a position in VNDA in Q2 2022 and has held it in 17 quarters since. The position peaked at $246K in Q1 2023. 58 funds tracked by Wall St. Rank hold VNDA as of Q2 2026.

  • Mirae Asset Global Investments held 2,689 shares of Vanda Pharmaceuticals worth $16.5K as of Q2 2026.
  • Mirae Asset Global Investments sold 394 Vanda Pharmaceuticals shares in Q2 2026, an estimated $2.57K.
  • Vanda Pharmaceuticals made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1511 holding.
  • Mirae Asset Global Investments first reported a position in Vanda Pharmaceuticals in Q2 2022 and has held it in 17 quarters since.
  • Mirae Asset Global Investments's Vanda Pharmaceuticals position peaked at $246K in Q1 2023.
  • 58 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.